Kidney Research and Clinical Practice

Korean Society of Nephrology (대한신장학회)
권호 표지

The Impact of Timing of Nephrology Referral on Prognosis in Patients with Diabetic Chronic Kidney Disease

당뇨병성 만성 신장병 환자에서 신장내과 전과 시기가 예후에 미치는 영향

Lee, Dong-Young;Choi, So-Young;Cho, Sung-Yeon;Park, Ji-Young;Lee, Sang-Ho;Ihm, Chun-Gyoo;Lee, Tae-Won
이동영;최소영;조성연;박지영;이상호;임천규;이태원

  • Published : 20090700
⟨ Previous Next ⟩

Abstract

Purpose:Diabetic patients with chronic kidney disease (CKD) are associated with a significantly poorer prognosis following renal replacement therapy (RRT) in comparison to those with nondiabetic CKD. To improve such prognosis, it is crucial to achieve a timely referral to nephrologists. This article evaluated the impact the timing of nephrology referral has on prognosis in patients with diabetic CKD. Methods:Retrospective study was conducted regarding 239 patients with diabetic CKD on RRT. Patients were grouped according to referral patterns with those referred more than 1 month prior to initiating dialysis designated as early referral (ER) group and those referred within 1 month as late referral (LR) group. Characteristics of patients and risk factors for 3-month and 1-year mortality were analyzed, and mortality rates of ER and LR groups were compared using Kaplan-Meier curves of 1- year mortality. Results:LR group showed a significantly higher (p=0.023) 1-year mortality rate and more frequently required urgent dialysis or angiocatheter and complicated congestive heart failure (CHF), pulmonary edema. Contrarily, ER group showed a significantly lower mortality rate (p=0.0179) based on Kaplan- Meier survival curve of 1-year mortality. According to logistic regression analysis, CVD (OR=7.695) and low total cholesterol level (OR=0.979) and CVD (OR=8.021), emergent dialysis (OR=3.734), and high HbA1C level (OR=1.528) were risk factors of significance of 3-month and 1-year mortality, respectively. Conclusion:Among diabetic patients with CKD, late-referred group was associated with a significantly higher rate of 1-year mortality. With LR as a risk factor of 1-year mortality according to univariate analysis, timing of referral is a critical prognostic factor.

목 적:당뇨병성 만성 신장병 환자에서의 투석 후 예후는 비당뇨병성 만성 신장병 환자에 비해 현저히 나쁘다. 예후를 향상시키기 위해서는 적기에 신장전문의에게 환자를 의뢰하고 적절한 시기에 신대체 요법을 시행 받는 것이 중요하다. 이에 본 연구자는 당뇨병성 만성 신장병으로 신대체 요법을 시행 받았던 환자들에서 신장내과 전과 시점이 환자의 예후에 미치는 영향을 알기 위해 이 연구를 계획하였다. 방 법:신대체 요법을 시작한 당뇨병성 만성 신장병 환자 239명을 대상으로 하였다. 환자군을 신장내과의뢰부터 신대체 요법까지 기간 1개월을 기준으로 조기와 후기 전과군 그리고 신장내과 의뢰 당시 만성신장병 단계의 2가지 기준으로 분류하였다. 환자군의 역학적 및 임상적 특징과 3개월과 1년 사망의 위험인자를 분석하였고 1년 Kaplan-Meier 생존곡선으로 조기와 후기 전과군의 생존률을 비교하였다. 결 과:후기 전과군이 1년 사망률이 의미 있게 높았으며 (p=0.023), 응급투석과 혈관도관 사용이 많았고 심부전, 폐부종 등 유병질환이 많았다. 1년 Kaplan-Meier 생존곡선에서 후기 전과군이 의미 있게 낮은 생존률을 보였다 (p=0.0179). 로지스틱 회귀분석에서 3개월 사망 위험인자는 뇌혈관질환 (OR=7.695), 낮은 총콜레스테롤 (OR=0.979)이 었고 1년 사망 위험인자는 뇌혈관질환 (OR=8.021), 응급투석 (OR=3.734), 높은 당화혈색소 (OR=1.528), 고령 (OR=1.081)이었다. 결 론:당뇨병성 만성 신장병 환자에서 후기 전과군의 1년 사망률이 의미 있게 높았고 단변량 분석에서 1년 사망위험인자이므로 전과 시기는 중요한 예후 인자이다. 또한 후기 전과군에서 응급투석과 혈관도관 사용이 많고 심부전과 폐부종 같은 유병질환이 많기 때문에 적절한 시기에 신장내과로 의뢰하는 것이 중요하다.

Keywords

References

  1. ESRD Registry Committee, Korean Society of Nephrology: Current Renal Replacement Therapy in Korea- Insan Memorial Dialysis Registry 2006-, Korean J Nephrol 27:S437-S465, 2008
  2. http://www.usrds.org. The 2008 USRDS Annual Data Report (ADR) Atlas, Volume Two: Atlas of End- Stage Renal Disease
  3. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Pork FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730, 1999 https://doi.org/10.1056/NEJM199912023412303
  4. Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H: Outcomes in patients with chronic kidney disease referred late to nephrologists: A Meta-analysis. Am J Med 120:1063-1070, 2007 https://doi.org/10.1016/j.amjmed.2007.04.024
  5. Frimat L, Loos-Ayav C, Panescu V, Cordebar N, Briancon S, Kessler M: Early referral to a nephrologist is associated with better outcomes in types 2 diabetes patients with end-stage renal disease, Diabetes Metab 30:67-74, 2004 https://doi.org/10.1016/S1262-3636(07)70091-5
  6. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (Suppl 1):S1-S266, 2002
  7. Lee YM, Lee HK, Kyung KO, Jang DS, Lee SY, Lee SJ, Na KR, Lee KW, Shin YT: The clinical impact of the referral pattern to nephrologist in patients with chronic renal failure. Korean J Med 67:625-634, 2004
  8. Kang WH, Oh HY, Shin YJ, Seol J, Kang M, Tak EY, Lee NS, Lee M, Ryu R, Song YH, Huh W, Kim YG, Kim DJ: Impact of early nephrology referral on factors correlated with hemodialysis patient's survival. Korean J Nephrol 25:243-250, 2006
  9. John Feehally, Jurgen Floege, Richard J. Johnson: Comprehensive Clinical Nephrology, 3rd edition, p.353
  10. Ratcliffe PJ, Phillips RE, Oliver DO: Late referral for maintenance dialysis. Br Med J(Clin Res Ed) 288: 441-443, 1984 https://doi.org/10.1136/bmj.288.6415.441
  11. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1-12, 2003
  12. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147, 2003 https://doi.org/10.7326/0003-4819-139-2-200307150-00013
  13. Kessler M, Frimat L, Panescu V, Briancon S: Impact of Nephrology Referral on early and midterm outcomes in ESRD: Epid$\acute{e}$miologie de I'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis 42: 474-485, 2003 https://doi.org/10.1016/S0272-6386(03)00805-9
  14. Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT: Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant 19:1808-1814, 2004 https://doi.org/10.1093/ndt/gfg573
  15. Agrawal V, Ghosh AK, Barnes MA, McCullough PA: Perception of indications for nephrology referral among internal medicine residents: a national online survey. Clin J Am Soc Nephrol 4:323-328, 2009 https://doi.org/10.2215/CJN.03510708
  16. Lewis P. Rowland, H. Houston Merritt: Merrit's neurology, 11th edition, 290
  17. Barry M. Brenner, Samuel A. Levine: Brenner & Rector's The Kidney. 8th edition, p.1960
  18. Suzuki T, Kanno Y, Nakamoto H, Okada H, Sugahara S, Suzuki H: Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism. Adv Perit Dial 19:148-154, 2003
  19. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Inverse Association between Lipid Levels and Mortality in Men with Chronic Kidney Disease Who Are Not Yet on Dialysis: Effects of Case Mix and the Malnutrition- Inflammation-Cachexia Syndrome. J Am Soc Nephrol 18:304-311, 2007 https://doi.org/10.1681/ASN.2006060674
  20. Afzali B, Haydar AA, Vinen K, Goldsmith DJ: From Finland to fatland: beneficial effects of statins for patients with chronic kidney disease. J Am Soc Nephrol 15:2161-2168, 2004 https://doi.org/10.1097/01.ASN.0000133252.07149.05
  21. Degoulet P, Legrain M, R$\acute{e}$ach I, Aim$\acute{e}$ F, Devri$\acute{e}$s C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31:103-110, 1982 https://doi.org/10.1159/000182627
  22. Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM: Can we improve early mortality in patients receiving renal replacement therapy? Kidney Int 57:2539-2545, 2000 https://doi.org/10.1046/j.1523-1755.2000.00113.x
  23. Soucie JM, McClellan WM: Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 7:2169-2175, 1996
  24. Wu MS, Yu CC, Yang CW, Wu CH, Haung JY, Hong JJ, Fan Chiang CY, Huang CC, Leu ML: Poor pre- dialysis glycaemic controls is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 12:2105-2110, 1997 https://doi.org/10.1093/ndt/12.10.2105
  25. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K: A1C and survival in maintenance hemodialysis patients. Diabetes Care 30:1049-1055, 2007 https://doi.org/10.2337/dc06-2127
  26. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD: VADT Investigators: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129-139, 2009 https://doi.org/10.1056/NEJMoa0808431
  27. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 284: 835-842, 2000 https://doi.org/10.1001/jama.284.7.835
  28. Martinez-Ramire HR, Jalomo-Martinez B, Cort$\acute{e}$s- Sanabria L, Rojas-Campos E, Barrag$\acute{a}$n G, Alfaro G, Cueto-Manzano AM: Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: A comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis 47:78-87, 2006 https://doi.org/10.1053/j.ajkd.2005.09.015
  29. http://www.usrds.org. Accessed December 26, 2007
  30. http://www.unos.org. Accessed January 17, 2007.
  31. Tzamaloukas AH, Yuan ZY, Balaskas E, Oreopoulos DG: CAPD in end stage patients with renal disease due to diabetes mellitus--an update. Adv Perit Dial 8:185-191, 1992
  32. Nelson CB, Port FK, Wolfe RA, Guire KE: Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 3:1147-1155, 1992
  33. Passadakis P, Thodis E, Vargemezis V, Oreopoulos D: Long-term survival with peritoneal dialysis in ESRD due to diabetes. Clin Nephrol 56: 257-270, 2001
  34. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler JH, Kliger A, Powe NR: Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 143: 174-183, 2005 https://doi.org/10.1001/archinte.143.1.174
  35. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program, NIH Publication No. 04-5230, 2004
  36. Lorenzo V, Marth M, Rufino M, Hern$\acute{a}$ndez D, Torres A, Ayus JC: Predialysis nephrologic Care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: An observational cohort study. Am J Kidney Dis 43: 999-1007, 2004 https://doi.org/10.1053/j.ajkd.2004.02.012